How Injecting Under Medical Supervision Could Help Fight The Opioid Epidemic
As officials struggle to fight the opioid epidemic that is plaguing the country, some big cities are considering creating "safe injection" sites. Addicts would be able to use their drugs under the watch of medical professionals, and they would be provided clean needles. While no city has submitted a formal plan, the idea is already stirring up controversy.
Dina Fine Maron, Health & Medicine Editor at Scientific American, explains the science behind safe injection sites. Allowing addicts to use drugs under supervision and with clean needles helps to reduce diseases associated with intravenous drug use such as HIV.
While no city in the United States has a "safe injection" site, Fine Maron says existing sites in Europe and Canada have proven to be a success. Data shows that opening these sites helps reduce opioid-related deaths and problems.
U.S. health officials are cutting isolation restrictions for Americans who test positive for the coronavirus and shortening the time that close contacts have to quarantine.
New Year celebrations are approaching and across the world there is an urge to party. But the desire to let loose is being countered by the highly transmissible omicron variant.
Carlo and Baker cover the latest developments after a devastating tornado outbreak over the weekend, plus an eye on Omicron and inflation, and not even Spielberg can save the box office.
Reusable rocket developer Stoke Space Technologies raised $65 million in a Series A round led by Breakthrough Energy Ventures, a firm founded by Bill Gates. Stoke says its reusable rockets provide the satellite industry with low-cost, on-demand access to and from orbit. As companies like SpacX and Blue Origin are also making commitments to rocket reusability, Stoke says it is taking a different approach with a system designed to be 100% reusable, comprised of rockets designed to fly daily, like an airplane. Stoke co-founder and CEO Andy Lapsa joins Cheddar News' Closing Bell to discuss.
Humans are set to return to a place we have not been in nearly 50 years: the moon. NASA's Artemis program is expected to have astronauts back on the lunar surface by 2025. NASA says it will use what it learns on the moon to take the next giant leap - sending the first astronauts to Mars. The Artemis program also includes contributions from private companies like SpaceX, as well as academic research institutions like Georgia Tech. Georgia Tech professor of practice and former NASA astronaut Sandra Magnus joins Future of Space: Humankind's Leap Forward to discuss.
The CDC warns that COVID-19 is rapidly spreading with Omicron variant cases doubling every two days in the United States. How do current vaccines hold up against the new strain, and what does it mean for your upcoming holiday travel? Cheddar News breaks things down with infectious diseases specialist Dr. William Schaffner of Vanderbilt University School of Medicine.
